title: Effects of NMDA receptor antagonists on probability discounting depend on the order of probability presentation.
abstract: Risky decision making can be measured using a probability-discounting procedure, in which animals choose between a small, certain reinforcer and a large, uncertain reinforcer. Recent evidence has identified glutamate as a mediator of risky decision making, as blocking the N-methyl-d-aspartate (NMDA) receptor with MK-801 increases preference for a large, uncertain reinforcer. Because the order in which probabilities associated with the large reinforcer can modulate the effects of drugs on choice, the current study determined if NMDA receptor ligands alter probability discounting using ascending and descending schedules. Sixteen rats were trained in a probability-discounting procedure in which the odds against obtaining the large reinforcer increased (n=8) or decreased (n=8) across blocks of trials. Following behavioral training, rats received treatments of the NMDA receptor ligands MK-801 (uncompetitive antagonist; 0, 0.003, 0.01, or 0.03mg/kg), ketamine (uncompetitive antagonist; 0, 1.0, 5.0, or 10.0mg/kg), and ifenprodil (NR2B-selective non-competitive antagonist; 0, 1.0, 3.0, or 10.0mg/kg). Results showed discounting was steeper (indicating increased risk aversion) for rats on an ascending schedule relative to rats on the descending schedule. Furthermore, the effects of MK-801, ketamine, and ifenprodil on discounting were dependent on the schedule used. Specifically, the highest dose of each drug decreased risk taking in rats in the descending schedule, but only MK-801 (0.03mg/kg) increased risk taking in rats on an ascending schedule. These results show that probability presentation order modulates the effects of NMDA receptor ligands on risky decision making.
authors.affiliation: Department of Psychological Science, Northern Kentucky University, USA. Electronic address: yatesj1@nku.edu.
authors.forename: Justin R
authors.initials: JR
authors.lastname: Yates
authors.affiliation: Department of Psychological Science, Northern Kentucky University, USA.
authors.forename: Kerry A
authors.initials: KA
authors.lastname: Breitenstein
authors.affiliation: Department of Psychological Science, Northern Kentucky University, USA.
authors.forename: Benjamin T
authors.initials: BT
authors.lastname: Gunkel
authors.affiliation: Department of Psychological Science, Northern Kentucky University, USA.
authors.forename: Mallory N
authors.initials: MN
authors.lastname: Hughes
authors.affiliation: Department of Psychological Science, Northern Kentucky University, USA.
authors.forename: Anthony B
authors.initials: AB
authors.lastname: Johnson
authors.affiliation: Department of Psychological Science, Northern Kentucky University, USA.
authors.forename: Katherine K
authors.initials: KK
authors.lastname: Rogers
authors.affiliation: Department of Psychological Science, Northern Kentucky University, USA.
authors.forename: Sara M
authors.initials: SM
authors.lastname: Shape
mesh_terms: D000818:Animals; D016291:Dizocilpine Maleate / Q000494:pharmacology; D007649:Ketamine / Q000494:pharmacology; D008297:Male; D010880:Piperidines / Q000494:pharmacology; D011336:Probability; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D012054:Reinforcement, Psychology
chemical_list: D010880:Piperidines; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D016291:Dizocilpine Maleate; C010739:ifenprodil
keywords: Glutamate; NMDA receptor; Probability discounting; Rat; Risky decision making